M.-P. Sunyach

656 total citations
16 papers, 452 citations indexed

About

M.-P. Sunyach is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, M.-P. Sunyach has authored 16 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in M.-P. Sunyach's work include Sarcoma Diagnosis and Treatment (12 papers), Vascular Tumors and Angiosarcomas (6 papers) and Cardiac tumors and thrombi (4 papers). M.-P. Sunyach is often cited by papers focused on Sarcoma Diagnosis and Treatment (12 papers), Vascular Tumors and Angiosarcomas (6 papers) and Cardiac tumors and thrombi (4 papers). M.-P. Sunyach collaborates with scholars based in France, Poland and Australia. M.-P. Sunyach's co-authors include Jean‐Yves Blay, Philippe Thiesse, I. Ray-Coquard, Dominique Ranchère‐Vince, Perrine Marec‐Bérard, Thierry Philip, Franck Chauvin, J.-Y. Bobin, Pierre Biron and Jean‐Paul Carret and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Radiotherapy and Oncology.

In The Last Decade

M.-P. Sunyach

14 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.-P. Sunyach France 7 351 214 134 131 89 16 452
Jaber Abbas Lebanon 12 214 0.6× 278 1.3× 137 1.0× 62 0.5× 118 1.3× 39 508
Olfa Derbel France 10 211 0.6× 209 1.0× 66 0.5× 107 0.8× 73 0.8× 24 403
Hongyu Wu United States 3 501 1.4× 252 1.2× 101 0.8× 65 0.5× 163 1.8× 4 661
Emmanuelle Tresch‐Bruneel France 11 349 1.0× 273 1.3× 41 0.3× 105 0.8× 62 0.7× 27 490
E. Gortzak Netherlands 8 645 1.8× 483 2.3× 133 1.0× 193 1.5× 114 1.3× 14 723
Kimitaka Miyajima Japan 9 246 0.7× 136 0.6× 94 0.7× 128 1.0× 67 0.8× 13 391
J.-Y. Bobin France 9 198 0.6× 152 0.7× 113 0.8× 75 0.6× 100 1.1× 24 358
Augustine Velez United States 9 250 0.7× 225 1.1× 27 0.2× 83 0.6× 136 1.5× 10 388
Steen Bærentzen Denmark 11 236 0.7× 134 0.6× 49 0.4× 94 0.7× 58 0.7× 23 328
K. Khanfir Switzerland 11 155 0.4× 214 1.0× 55 0.4× 96 0.7× 185 2.1× 23 404

Countries citing papers authored by M.-P. Sunyach

Since Specialization
Citations

This map shows the geographic impact of M.-P. Sunyach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.-P. Sunyach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.-P. Sunyach more than expected).

Fields of papers citing papers by M.-P. Sunyach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.-P. Sunyach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.-P. Sunyach. The network helps show where M.-P. Sunyach may publish in the future.

Co-authorship network of co-authors of M.-P. Sunyach

This figure shows the co-authorship network connecting the top 25 collaborators of M.-P. Sunyach. A scholar is included among the top collaborators of M.-P. Sunyach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.-P. Sunyach. M.-P. Sunyach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sargos, Paul, M.-P. Sunyach, Anne Ducassou, et al.. (2025). Results of a phase Ib study of olaparib with concomitant radiotherapy in soft-tissue sarcoma: a French sarcoma group study. Annals of Oncology. 36(5). 592–600. 1 indexed citations
2.
Brahmi, Mehdi, Hélène Vanacker, Marie Karanian, et al.. (2025). High expression level of ERBB2 and efficacy of trastuzumab deruxtecan in desmoplastic small round cell tumour: a monocentric case series report. ESMO Open. 10(2). 104133–104133.
3.
Brahmi, Mehdi, Armelle Dufresne, Hélène Vanacker, et al.. (2023). 1975P Systemic therapy for KIT/PDGFRA wild-type GIST. Annals of Oncology. 34. S1054–S1054. 4 indexed citations
4.
Nassif, Elise F., Jean‐Yves Blay, Christophe Massard, et al.. (2022). Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials. ESMO Open. 7(2). 100425–100425. 4 indexed citations
5.
Péchoux, C. Le, Paul Sargos, Laurence Moureau-Zabotto, et al.. (2021). Conformal radiotherapy in management of soft tissue sarcoma in adults. Cancer/Radiothérapie. 26(1-2). 377–387. 9 indexed citations
6.
Marec‐Bérard, Perrine, Serge Aho, Claire Berger, et al.. (2020). Clinical management of adolescents and young adults suffering from sarcoma in the French Rhône-Alpes region: A prospective exhaustive cohort with 10 years follow up. European Journal of Surgical Oncology. 46(7). 1301–1309. 4 indexed citations
7.
Bonvalot, S., Piotr Rutkowski, Juliette Thariat, et al.. (2018). A phase II/III trial of hafnium oxide nanoparticles activated by radiotherapy in the treatment of locally advance soft tissue sarcoma of the extremity and trunk wall. Annals of Oncology. 29. viii753–viii753. 9 indexed citations
8.
Malet, C., et al.. (2017). 1. Dosimetric comparison of the treatment of Hodgkin’s lymphoma, 3D conformal radiotherapy vs. helical tomotherapy. Physica Medica. 44. 28–28. 1 indexed citations
9.
Moureau-Zabotto, Laurence, M. Delannes, C. Le Péchoux, et al.. (2016). Prise en charge des sarcomes des tissus mous des membres par radiothérapie externe. Cancer/Radiothérapie. 20(2). 133–140. 4 indexed citations
10.
Eberst, Lauriane, Magali Morelle, M.-P. Sunyach, et al.. (2016). Focalized treatment strategy for patients with 1 to 5 breast cancer brain metastasis: a retrospective study of 70 patients treated with surgery or stereotactic radiosurgery. Annals of Oncology. 27. vi77–vi77. 1 indexed citations
11.
Cassier, Philippe A., G. Kantor, Sylvie Bonvalot, et al.. (2014). Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study. Annals of Oncology. 25(9). 1854–1860. 44 indexed citations
12.
Falk, Alexander T., Laurence Moureau-Zabotto, M. Ouali, et al.. (2014). Effect on Survival of Local Ablative Treatment of Metastases from Sarcomas: A Study of the French Sarcoma Group. Clinical Oncology. 27(1). 48–55. 64 indexed citations
14.
Confavreux, C, A. Lurkin, N. Mitton, et al.. (2006). Sarcomas and malignant phyllodes tumours of the breast – A retrospective study. European Journal of Cancer. 42(16). 2715–2721. 82 indexed citations
15.
Ray-Coquard, I., Philippe Thiesse, Dominique Ranchère‐Vince, et al.. (2004). Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas. Annals of Oncology. 15(2). 307–315. 152 indexed citations
16.
Ray-Coquard, I., Dominique Ranchère‐Vince, Philippe Thiesse, et al.. (2003). Evaluation of core needle biopsy as a substitute to open biopsy in the diagnosis of soft-tissue masses. European Journal of Cancer. 39(14). 2021–2025. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026